Computational evaluation of natural compounds as potential inhibitors of human PEPCK-M: an alternative for lung cancer therapy

References

• Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–1544. doi:10.1016/S0140-6736(16)31012-127733281
   PubMed Web of Science ®Google Scholar
• Basumallik N, Agarwal M. Cancer, lung, small cell (oat cell); 2018 Available from: http://www.ncbi.nlm.nih.gov/pubmed/29494065. Accessed October 26, 2018.
   Google Scholar
• Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong K-K. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14(8):535–546. doi:10.1038/nrc377525056707
   PubMed Web of Science ®Google Scholar
• Harris AL. Hypoxia — a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2(1):38–47. doi:10.1038/nrc70411902584
   PubMed Web of Science ®Google Scholar
• Birsoy K, Possemato R, Lorbeer FK, et al. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature. 2014;508(1):108–112. doi:10.1038/nature1311024670634
   PubMed Web of Science ®Google Scholar
• Vincent EE, Sergushichev A, Griss T, et al. Mitochondrial phosphoenolpyruvate carboxykinase regulates metabolic adaptation and enables glucose-independent tumor growth. Mol Cell. 2015;60(2):195–207. doi:10.1016/j.molcel.2015.08.01326474064
   PubMed Web of Science ®Google Scholar
• Leithner K, Hrzenjak A, Trötzmüller M, et al. PCK2 activation mediates an adaptive response to glucose depletion in lung cancer. Oncogene. 2015;34(8):1044–1050. doi:10.1038/onc.2014.4724632615
   PubMed Web of Science ®Google Scholar
• Balsa-Martinez E, Puigserver P. Cancer cells hijack gluconeogenic enzymes to fuel cell growth. Mol Cell. 2015;60(4):509–511. doi:10.1016/j.molcel.2015.11.00526590709
   PubMed Web of Science ®Google Scholar
• Montal ED, Dewi R, Bhalla K, et al. PEPCK coordinates the regulation of central carbon metabolism to promote cancer cell growth. Mol Cell. 2015;60(4):571–583. doi:10.1016/j.molcel.2015.09.02526481663
   PubMed Web of Science ®Google Scholar
• Beale EG, Harvey BJ, Forest C. PCK1 and PCK2 as candidate diabetes and obesity genes. Cell Biochem Biophys. 2007;48(2–3):89–95. doi:10.1007/s12013-007-0025-617709878
   PubMed Web of Science ®Google Scholar
• Yang J, Kalhan SC, Hanson RW. What is the metabolic role of phosphoenolpyruvate carboxykinase? J Biol Chem. 2009;284(40):27025–27029. doi:10.1074/jbc.R109.04054319636077
   PubMed Web of Science ®Google Scholar
• Méndez-Lucas A, Hyroššová P, Novellasdemunt L, Viñals F, Perales JC. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availability. J Biol Chem. 2014;289(32):22090–22102. doi:10.1074/jbc.M114.56692724973213
   PubMed Web of Science ®Google Scholar
• Carlson GM, Holyoak T. Structural insights into the mechanism of phosphoenolpyruvate carboxykinase catalysis. J Biol Chem. 2009;284(40):27037–27041. doi:10.1074/jbc.R109.04056819638345
   PubMed Web of Science ®Google Scholar
• Johnson TA, Holyoak T. The Ω-Loop lid domain of phosphoenolpyruvate carboxykinase is essential for catalytic function. Biochemistry. 2012;51(47):9547–9559. doi:10.1021/bi301278t23127136
   PubMed Web of Science ®Google Scholar
• Balan MD, McLeod MJ, Lotosky WR, Ghaly M, Holyoak T. Inhibition and allosteric regulation of monomeric phosphoenolpyruvate carboxykinase by 3-Mercaptopicolinic acid. Biochemistry. 2015;54(38):5878–5887. doi:10.1021/acs.biochem.5b0082226322521
   PubMed Web of Science ®Google Scholar
• Robinson BH, Oei J. 3-Mercaptopicolinic acid, a preferential inhibitor of the cytosolic phosphoenolpyruvate carboxykinase. FEBS Lett. 1975;58(1–2):12–15. doi:10.1016/0014-5793(75)80214-61225570
   PubMed Web of Science ®Google Scholar
• Hidalgo J, Latorre P, Carrodeguas JA, Velázquez-Campoy A, Sancho J, López-Buesa P. Inhibition of pig phosphoenolpyruvate carboxykinase isoenzymes by 3-Mercaptopicolinic acid and novel inhibitors. PLoS One. 2016;11(7):1–17. doi:10.1371/journal.pone.0159002
   Web of Science ®Google Scholar
• Stiffin RM, Sullivan SM, Carlson GM, Holyoak T. Differential inhibition of cytosolic PEPCK by substrate analogues. Kinetic and structural characterization of inhibitor recognition. Biochemistry. 2008;47(7):2099–2109. doi:10.1021/bi702066218197707
   PubMed Web of Science ®Google Scholar
• Patridge E, Gareiss P, Kinch MS, Hoyer D. An analysis of FDA-approved drugs: natural products and their derivatives. Drug Discov Today. 2016. doi:10.1016/j.drudis.2015.01.009
   Web of Science ®Google Scholar
• Koch MA, Schuffenhauer A, Scheck M, et al. Charting biologically relevant chemical space: a structural classification of natural products (SCONP). Proc Natl Acad Sci. 2005. doi:10.1073/pnas.0503647102
   Web of Science ®Google Scholar
• Rodrigues T, Reker D, Schneider P, Schneider G. Counting on natural products for drug design. Nat Chem. 2016;8(6):531–541. doi:10.1038/nchem.247927219696
   PubMed Web of Science ®Google Scholar
• Rawlins MD. Cutting the cost of drug development? Nat Rev Drug Discov. 2004;3(4):360–364. doi:10.1038/nrd134715060531
   PubMed Web of Science ®Google Scholar
• Schneider G, Fechner U. Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov. 2005;4(8):649–663. doi:10.1038/nrd179916056391
   PubMed Web of Science ®Google Scholar
• Aung T, Qu Z, Kortschak R, Adelson D. Understanding the effectiveness of natural compound mixtures in cancer through their molecular mode of action. Int J Mol Sci. 2017;18(3):656. doi:10.3390/ijms18030656
   PubMed Web of Science ®Google Scholar
• Holyoak T, Sullivan SM, Nowak T. Structural insights into the mechanism of PEPCK catalysis †, ‡. Biochemistry. 2006;45(27):8254–8263. doi:10.1021/bi060269g16819824
   PubMed Web of Science ®Google Scholar
• Dunten P, Belunis C, Crowther R, et al. Crystal structure of human cytosolic phosphoenolpyruvate carboxykinase reveals a new GTP-binding site. J Mol Biol. 2002;316(2):257–264. doi:10.1006/jmbi.2001.536411851336
   PubMed Web of Science ®Google Scholar
• Webb B, Sali A, Comparative protein structure modeling using MODELLER In: Current Protocols in Bioinformatics. Vol. 2016 Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2016 5.6.1-5.6.37. doi:10.1002/cpbi.3
   Google Scholar
• Shen M-Y, Sali A. Statistical potential for assessment and prediction of protein structures. Protein Sci. 2006;15(11):2507–2524. doi:10.1110/ps.06241660617075131
   PubMed Web of Science ®Google Scholar
• Lüthy R, Bowie JU, Eisenberg D. Assessment of protein models with three-dimensional profiles. Nature. 1992;356(6364):83–85. doi:10.1038/356083a01538787
   PubMed Web of Science ®Google Scholar
• Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 1993;2(9):1511–1519. doi:10.1002/pro.55600209168401235
   PubMed Web of Science ®Google Scholar
• Chen VB, Arendall WB, Headd JJ, et al. MolProbity : all-atom structure validation for macromolecular crystallography. Acta Crystallogr Sect D Biol Crystallogr. 2010;66(1):12–21. doi:10.1107/S090744490904207320057044
   PubMedGoogle Scholar
• Koes DR, Camacho CJ. Pharmer: efficient and exact pharmacophore search. J Chem Inf Model. 2011;51(6):1307–1314. doi:10.1021/ci200097m21604800
   PubMed Web of Science ®Google Scholar
• Irwin JJ, Shoichet BK. ZINC - A free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005;45(1):177–182. doi:10.1021/ci049714+15667143
   PubMed Web of Science ®Google Scholar
• Koes DR, Camacho CJ. ZINCPharmer: pharmacophore search of the ZINC database. Nucleic Acids Res. 2012;40(W1):W409–W414. doi:10.1093/nar/gks37822553363
   PubMed Web of Science ®Google Scholar
• Bas DC, Rogers DM, Jensen JH. Very fast prediction and rationalization of pKa values for protein-ligand complexes. Proteins Struct Funct Genet. 2008;73(3):765–783. doi:10.1002/prot.2210218498103
   PubMed Web of Science ®Google Scholar
• Sullivan SM, Holyoak T. Structures of rat cytosolic PEPCK: insight into the mechanism of phosphorylation and decarboxylation of oxaloacetic acid †, ‡. Biochemistry. 2007;46(35):10078–10088. doi:10.1021/bi701038x17685635
   PubMed Web of Science ®Google Scholar
• Kim S, Thiessen PA, Bolton EE, et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44(D1):D1202–D1213. doi:10.1093/nar/gkv95126400175
   PubMed Web of Science ®Google Scholar
• Cereto-Massagué A, Guasch L, Valls C, Mulero M, Pujadas G, Garcia-Vallvé S. DecoyFinder: an easy-to-use python GUI application for building target-specific decoy sets. Bioinformatics. 2012;28(12):1661–1662. doi:10.1093/bioinformatics/bts24922539671
   PubMed Web of Science ®Google Scholar
• Mysinger MM, Carchia M, Irwin JJ, Shoichet BK. Directory of Useful Decoys, Enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem. 2012;55(14):6582–6594. doi:10.1021/jm300687e22716043
   PubMed Web of Science ®Google Scholar
• Wetzel S, Klein K, Renner S, et al. Interactive exploration of chemical space with scaffold hunter. Nat Chem Biol. 2009;5(8):581–583. doi:10.1038/nchembio.18719561620
   PubMed Web of Science ®Google Scholar
• Djoumbou Feunang Y, Eisner R, Knox C, et al. ClassyFire: automated chemical classification with a comprehensive, computable taxonomy. J Cheminform. 2016;8(1):1–20. doi:10.1186/s13321-016-0174-y26807156
   PubMed Web of Science ®Google Scholar
• Lagorce D, Sperandio O, Baell JB, Miteva MA, Villoutreix BO. FAF-drugs3: a web server for compound property calculation and chemical library design. Nucleic Acids Res. 2015;43(W1):W200–W207. doi:10.1093/nar/gkv35325883137
   PubMed Web of Science ®Google Scholar
• Hiller K, Grote A, Scheer M, Münch R, Jahn D. PrediSi: prediction of signal peptides and their cleavage positions. Nucleic Acids Res. 2004. doi:10.1093/nar/gkh378
   Web of Science ®Google Scholar
• Matte A, Goldie H, Sweet RM, Delbaere LTJ. Crystal structure of Escherichia coli phosphoenolpyruvate carboxykinase: a new structural family with the P-loop nucleoside triphosphate hydrolase fold. J Mol Biol. 1996;256(1):126–143. doi:10.1006/jmbi.1996.00728609605
   PubMed Web of Science ®Google Scholar
• Hsin K-Y, Matsuoka Y, Asai Y, et al. systemsDock: a web server for network pharmacology-based prediction and analysis. Nucleic Acids Res. 2016;44(W1):W507–W513. doi:10.1093/nar/gkw33527131384
   PubMed Web of Science ®Google Scholar
• Abolhassani M, Guais A, Sanders E, et al. Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice. Invest New Drugs. 2012;30(4):1331–1342. doi:10.1007/s10637-011-9692-721655919
   PubMed Web of Science ®Google Scholar
• Jena BS, Jayaprakasha GK, Singh RP, Sakariah KK. Chemistry and biochemistry of (−)-hydroxycitric acid from garcinia. J Agric Food Chem. 2002;50(1):10–22. doi:10.1021/jf010753k11754536
   PubMed Web of Science ®Google Scholar
• Lindqvist Y, Schneider G, Vihko P. Three-dimensional structure of rat acid phosphatase in complex with L(+)-tartrate. J Biol Chem. 1993;268(28):20744–20746. Available from:: http://www.ncbi.nlm.nih.gov/pubmed/84078988407898
   PubMed Web of Science ®Google Scholar
• LaCount MW, Handy G, Lebioda L. Structural origins of l(+)-tartrate inhibition of human prostatic acid phosphatase. J Biol Chem. 1998;273(46):30406–30409. doi:10.1074/jbc.273.46.304069804805
   PubMed Web of Science ®Google Scholar
• Gutman EB, Sproul EE, Gutman AB. Significance of increased phosphatase activity of bone at the site of osteoplastic metastases secondary to carcinoma of the prostate gland. Am J Cancer. 1936;28(3):485–495. doi:10.1158/ajc.1936.485a
   Google Scholar
• Son B, Jun SY, Seo H, et al. Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer. Sci Rep. 2016;6(1):21986. doi:10.1038/srep2198626906215
   PubMed Web of Science ®Google Scholar
• Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002. doi:10.1021/jm020017n
   Web of Science ®Google Scholar
• Egan WJ, Merz KM, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem. 2000. doi:10.1021/jm000292e
   Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23(1–3):3–25. doi:10.1016/j.addr.2012.09.019
   Web of Science ®Google Scholar
• Tan W, Wang H, Chen Y, et al. Molecular aptamers for drug delivery. Trends Biotechnol. 2011;29(12):634–640. doi:10.1016/j.tibtech.2011.06.00921821299
   PubMed Web of Science ®Google Scholar